drugset / Trial / NCT05368935
Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study is being conducted to evaluate the major Nitazoxanide (NTZ) active metabolite in adult participants with renal impairment and healthy adults.
Timeline
- Start
- 2022-04-25
- Primary completion
- 2022-09-04
- Completion
- 2022-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitazoxanide | Other / unclassified | 500 mg | Oral |